Back

Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

30 August 2024 (08:51 - 09:09)
Organised by: Logo
Congress Presentation Part of: Biomarkers to guide the treatment of heart failure: where are we going? Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yuling Yu

Leuven (Belgium)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on biomarkers to guide the treatment of heart failure: where are we going?
Professor J. Januzzi (Boston, US)
Slides Video
Presentation thumbnail
Outcomes and effects of sacubitril/valsartan according to NT-proBNP level in patients with heart failure: a patient-level pooled analysis of the PARADIGM-HF and PARAGON-HF trials
Doctor T. Kondo (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Heart failure and renal outcomes in patient treated with GLP1 agonists.
Doctor N. del-Cuerpo-Salinas (Sant Joan d'Alacant, ES)
Abstract Slides Video
Presentation thumbnail
Liver function tests in patients receiving high-intensity care after hospital admission for acute heart failure: the STRONG-HF trial
Doctor P. Myhre (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers to guide the treatment of heart failure: where are we going?
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 08:51 CET
You may be interested in
thumbnail
Congress Presentation
Diagnostic and prognostic use of circulating biomarkers of fibrosis
thumbnail
Congress Presentation
Biomarkers profiles to identify new targets
thumbnail
Congress Presentation
Antifibrotic agents

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources